MSCI ACWI IMI Virology Index
The MSCI ACWI IMI Virology Index is based on the MSCI ACWI IMI Index, its parent index, and includes large, mid and small-cap securities across Developed Markets (DM) and Emerging Markets (EM) countries. The index aims to represent the performance of a set of companies that are associated with research and development into, as well as the commercialization of anti-viral and vaccine products, which are used to treat a range of infectious diseases.
Data as of Jan. 31, 2025
ESG metrics
No data available for this index